Phone (Mobile)
+1 617 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(617) 941-7500
Phone (HQ)
❅❅❅❅❅@egenesisbio.com
Office Address (HQ)
101 Cambridgepark Dr Ste 200, Cambridge, Massachusetts, 02140, United States
Office Address (HQ)
Get 10 Free Leads on us
Use our Chrome Extension & instantly connect with prospects
Michael Curtis
According to Datanyze information, these are Michael Curtis's contact details. Reveal the hidden information below for FREE!
Phone (Mobile)
+1 617 ❅❅❅ ❅❅❅❅
Phone (Mobile)
Phone (HQ)
(617) 941-7500
Phone (HQ)
❅❅❅❅❅@egenesisbio.com
Office Address (HQ)
101 Cambridgepark Dr Ste 200, Cambridge, Massachusetts, 02140, United States
Office Address (HQ)
Michael Curtis works as a President & Chief Executive Officer at eGenesis, which is a Business Services company with an estimated 97 employees; and founded in 2015. They are part of the Executive team within the C-Suite Department and their management level is C-Level. Michael graduated from and is currently based in Cambridge, United States. They used to work at Cadent Therapeutics and Cadent Therapeutics and have used the following emails: @egenesisbio.com, @infi.com.
Quickly connect with Michael before someone else does! 👏
Michael Curtis's career began less then a year ago. Prior to joining eGenesis, Michael worked at 12 companies.
President, Research & Development
Senior Advisor
President Head of Research & Development
Entrepreneur In Residence
President & Chief Executive Officer
Senior VP, Product Development & Regulatory Affairs
Vice President, Product Development
Vice President, Pharmaceutical Development
Associate Director
Associate Director
Scientist
Scientist
undergraduate degrees
University of Colorado
J. D.
eGenesis
101 Cambridgepark Dr Ste 200, Cambridge, Massachusetts, 02140, United States
97
$20.5 M
Business Services, Research & Development, Manufacturing, Pharmaceuticals
Get Full Profile Access
Ice Breakers
Imagine you could know all about eGenesis - Michael Curtis’s company, before you contact them. Warm up a cold prospect with Datanyze icebreakers
Michael’s company in the news
Follow the Money: T Cell Engineering, Kidney Transplants, Intravascular Imaging Technology, More
September 26, 2024
Investors back eGenesis in pursuing pig-to-human transplant study - Healio
September 20, 2024
eGenesis Raises $191 Million Series D Financing to Advance Lead Program for Kidney Transplant
September 4, 2024
See more
Insights to Break the Ice
In your first interaction
Michael is located in United States
eGenesis’s Funding
Last funding
$191M
September 4, 2024
Total raised
$456M
Work Colleague
See Michael Curtis's coworkers out of eGenesis's 97 employees